Enyu Rao

University of North Carolina at Chapel Hill — United States

Immunology and Microbiology · Life Sciences

15h-index1.5kcitations48works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(24), Cancer Immunotherapy and Biomarkers(20), Chemokine receptors and signaling(14), Peroxisome Proliferator-Activated Receptors(13), Immune Cell Function and Interaction(7)

Publications48 total

Preclinical assessment of the efficacy of B7-H3 CAR-T in renal cell carcinoma
UNC Libraries·2025Open Access
Venous Resection and Reconstruction in Pancreatic Ductal Adenocarcinoma (PDAC): Experience in a Tertiary Centre
HPB·2025
WNT2 blockade augments antitumor immunity by attenuating myeloid‐derived suppressor cells in colorectal cancer
MedComm – Oncology·2024· 4 citedOpen Access
Preclinical assessment of the efficacy of B7-H3 CAR-T in renal cell carcinoma
Molecular Immunology·2024· 2 citedOpen Access
Supplementary Figure S6 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S1 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S7 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S5 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S3 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Data from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S8 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S3 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S6 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S7 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S5 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S8 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S2 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S2 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S1 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
Supplementary Figure S4 from Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Hua Liang(24), Yuzhu Hou(24), Xiaona Huang(24), Ralph R. Weichselbaum(23), Xinshuang Yu(22), Liangliang Wang(22), Jason Bugno(21), Everett E. Vokes(21), Jiaai Wang(21), Matthias Mack(20), Steven J. Chmura(20), Sean Z. Luo(20), Sean P. Pitroda(20), Kaiting Yang(20), András Piffkó(19), Carlos Martínez(19), Bing Li(18), Yuwen Zhang(15), Margot P. Cleary(10), Yanwen Sun(9)